Study of the Combination of Bortezomib, Dexamethasone, and Rituximab in Patients With Waldenstroms Macroglobulinemia
Clinical trial NCT00250926 · COMPLETED
Trial details
- NCT number
- NCT00250926
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-10-01
- Primary completion
- 2007-03-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.